by the end of 2 weeks of active treatment , the percentages of patients with no edema were 26 % , 44 % , and 31 % for the indapamide groups ( 2.5 , 5.0 , and 10.0 mg ) , respectively , and 40 % for the hydrochlorothiazide group ( 100 mg ) .
C0013604
edema
C0021186
indapamide